Fulvestrant in the management of postmenopausal women with advanced, endocrine-responsive breast cancer (vol 7, pg 173, 2011)

被引：0
|
作者：
Oakman, C.
Moretti, E.
Santarpia, L.
Di Leo, A.
机构：
来源：
FUTURE ONCOLOGY | 2011年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：803 / 806
页数：4
相关论文
共 50 条
  • [1] Fulvestrant in the management of postmenopausal women with advanced, endocrine-responsive breast cancer
    Oakman, Catherine
    Moretti, Erica
    Santarpia, Libero
    Di Leo, Angelo
    [J]. FUTURE ONCOLOGY, 2011, 7 (02) : 173 - 186
  • [2] Fulvestrant in postmenopausal women with advanced breast cancer
    Bross, PF
    Baird, A
    Chen, G
    Jee, JM
    Lostritto, RT
    Morse, DE
    Rosario, LA
    Williams, GM
    Yang, PL
    Rahman, A
    Williams, G
    Pazdur, R
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (12) : 4309 - 4317
  • [3] Fulvestrant in the treatment of postmenopausal women with advanced breast cancer
    Gradishar, W
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (03) : 445 - 453
  • [4] Musculoskeletal events associated with the management of endocrine-responsive breast cancer
    Al-Janadi, Anas
    Hrinczenko, Borys
    Chaudhary, Vijay
    Chitneni, Shalini
    Ali, Sarah
    Saultz, Jennifer
    Dimitrov, Nikolay V.
    [J]. ONCOLOGY REVIEWS, 2010, 4 (03) : 185 - 189
  • [5] Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: Past, present and future recommendations
    Thuerlimann, Beat
    Koeberle, Dieter
    Senn, Hans-Joerg
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (01) : 46 - 52
  • [6] Endocrine response after prior treatment with fulvestrant (Fasiodex®) in postmenopausal women with advanced breast cancer
    Cheung, K
    Robertson, JFR
    Scott, N
    Owers, R
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S98 - S99
  • [7] Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice (vol 20, pg 862, 2018)
    Blancas, I.
    Fontanillas, M.
    Conde, V.
    Lao, J.
    Martinez, E.
    Sotelo, M. J.
    Jaen, A.
    Bayo, J. L.
    Carabantes, F.
    Illarramendi, J. J.
    Gordon, M. M.
    Cruz, J.
    Garcia-Palomo, A.
    Mendiola, C.
    Perez-Ruiz, E.
    Bofill, J. S.
    Baena-Canada, J. M.
    Janez, N. M.
    Esquerdo, G.
    Ruiz-Borrego, M.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (12): : 1631 - 1632
  • [8] Insights Into the Place of Fulvestrant for the Treatment of Advanced Endocrine Responsive Breast Cancer
    Howell, Anthony
    Bergh, Jonas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) : 4548 - 4550
  • [9] Fulvestrant in heavily pretreated postmenopausal women with advanced breast cancer
    Martinez Marin, Virginia
    Munoz Martin, Andres J.
    Vinuela Beneitez, M. Carmen
    Garcia Alfonso, Pilar
    Alonso Munoz, Antonio
    Perez Manga, Gumersindo
    [J]. MEDICINA CLINICA, 2009, 133 (10): : 371 - 374
  • [10] Evidence of continued sensitivity to endocrine agents in postmenopausal women with advanced breast cancer progressing on fulvestrant ('Faslodex®')
    Vergote, I
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 288 - 288
12345